<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="fhm" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">fhm</book-part-id>
      <title-group>
        <title>Familial Hemiplegic Migraine</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jen</surname>
            <given-names>Joanna C</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>jjen@ucla.edu</email>
          <aff>Department of Neurology<break/>UCLA School of Medicine<break/>Los Angeles, California</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2001-07-17" date-type="created">
          <day>17</day>
          <month>7</month>
          <year>2001</year>
        </date>
        <date iso-8601-date="2015-05-14" date-type="updated">
          <day>14</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date iso-8601-date="2007-01-04" date-type="revised">
          <day>4</day>
          <month>1</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="fevr" document-type="chapter">Familial Exudative Vitreoretinopathy, Autosomal Dominant</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="hyperchol" document-type="chapter">Familial Hypercholesterolemia</related-object>
      <abstract id="fhm.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Familial hemiplegic migraine (FHM) falls within the category of migraine with aura. In migraine with aura (including familial hemiplegic migraine) the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include <italic toggle="yes">visual disturbance</italic> (most common), <italic toggle="yes">sensory loss</italic> (e.g., numbness or paresthesias of the face or an extremity), and <italic toggle="yes">dysphasia</italic> (difficulty with speech); FHM must include <italic toggle="yes">motor involvement</italic>, i.e., hemiparesis (weakness of an extremity). Hemiparesis occurs with at least one other symptom during FHM aura. Neurologic deficits with FHM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. FHM is often earlier in onset than typical migraine, frequently beginning in the first or second decade; the frequency of attacks tends to decrease with age. Approximately 40%-50% of families with FHM1 have cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia. Cerebral infarction and death have rarely been associated with hemiplegic migraine.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnostic criteria for FHM: (1) fulfills criteria for migraine with aura; (2) aura includes some degree of hemiparesis and may be prolonged; (3) at least one first-degree relative (i.e., parent, sib, offspring) has identical attacks. Three genes are known to be associated with FHM: <italic toggle="yes">CACNA1A</italic> (FHM1), <italic toggle="yes">ATP1A2</italic> (FHM2), and <italic toggle="yes">SCN1A</italic> (FHM3).</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> A trial of acetazolamide for individuals with FHM1 or a trial of standard migraine prophylactic drugs (tricyclic antidepressants, beta blockers, calcium channel blockers) for all FHM types may be warranted for frequent attacks. Antiepileptic treatment may be necessary for seizures, which are prevalent in FHM2.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Vasoconstricting agents because of the risk of stroke; cerebral angiography as it may precipitate a severe attack.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>FHM is inherited in an autosomal dominant manner. Because the diagnosis of FHM requires at least one affected first-degree relative, most individuals diagnosed with familial hemiplegic migraine have an affected parent. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutation is unknown. Each child of an individual with familial hemiplegic migraine has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family has been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="fhm.Diagnosis">
        <title>Diagnosis</title>
        <sec id="fhm.Diagnostic_Criteria">
          <title>Diagnostic Criteria</title>
          <p>The diagnosis of familial hemiplegic migraine (FHM) relies on clinical diagnostic criteria. Two sets of criteria have been proposed:</p>
          <p>
            <bold>Criteria adapted from the </bold>
            <xref ref-type="bibr" rid="fhm.REF.headache_classification_subcommittee_of_the_international_headache_society.2004.9">
              <bold>Headache Classification Subcommittee of the International Headache Society [2004]</bold>
            </xref>
            <bold> (</bold>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ihs-classification.org/en/">
              <bold>full text</bold>
            </ext-link>
            <bold>)</bold>
          </p>
          <p>Familial hemiplegic migraine (HM) is a category of migraine with aura (MA). Diagnostic criteria for HM are as follows:</p>
          <list list-type="bullet">
            <list-item>
              <p>Headaches fulfill criteria for MA (see Note).</p>
            </list-item>
            <list-item>
              <p>Aura includes some degree of hemiparesis and may be prolonged but fully reversible.</p>
            </list-item>
            <list-item>
              <p>HM is categorized as familial if at least one first-degree relative (i.e., parent, sib, and/or offspring) or second-degree relative has identical attacks.</p>
            </list-item>
            <list-item>
              <p>HM is sporadic if no first- or second-degree relative meets criteria for hemiplegic migraine.</p>
            </list-item>
          </list>
          <p>Note: Migraine with aura (MA) is an idiopathic, recurring disorder of neurologic symptoms unequivocally localizable to the cerebral cortex or brain stem. The aura usually develops over a period of five to 20 minutes and lasts less than 60 minutes. Headache, nausea and/or photophobia usually follow neurologic aura symptoms, either immediately or after a symptom-free interval of less than an hour. The headache usually lasts four to 72 hours but may be completely absent (acephalagia). Diagnostic criteria for MA:</p>
          <list list-type="bullet">
            <list-item>
              <p>At least two episodes characterized by three or more of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>One or more aura symptoms are fully reversible, indicating focal cerebral cortical and/or brain stem dysfunction.</p>
                </list-item>
                <list-item>
                  <p>At least one aura symptom develops gradually over more than four minutes, or two or more symptoms occur in succession.</p>
                </list-item>
                <list-item>
                  <p>No aura symptom lasts more than 60 minutes. If more than one aura symptom is present, duration of symptoms is proportionally increased.</p>
                </list-item>
                <list-item>
                  <p>Headache follows aura with a symptom-free interval of less than 60 minutes (headache may also begin before or simultaneously with the aura).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Ruling out of other classes of headache (i.e., head trauma, vascular disorders, nonvascular intracranial disorders, substance use or their withdrawal, non-cephalic infection, metabolic disorder, pain associated with other facial or cranial disorders)</p>
            </list-item>
          </list>
          <p>
            <bold>Criteria proposed by </bold>
            <xref ref-type="bibr" rid="fhm.REF.thomsen.2002.1379">
              <bold>Thomsen et al [2002]</bold>
            </xref>
            <bold>*</bold>
          </p>
          <p>At least two attacks that meet all of the following criteria:</p>
          <list list-type="bullet">
            <list-item>
              <p>Fully reversible symptoms including motor weakness and at least one of the following: visual, sensory, or speech disturbance</p>
            </list-item>
            <list-item>
              <p>At least two of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>At least one aura symptom develops gradually over at least five minutes, or symptoms occur in succession.</p>
                </list-item>
                <list-item>
                  <p>Each aura symptom lasts less than 24 hours.</p>
                </list-item>
                <list-item>
                  <p>Some degree of headache is associated with the aura.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Not attributed to another disorder</p>
            </list-item>
            <list-item>
              <p>At least one first- or second-degree relative with migraine with aura including motor weakness and fulfilling all of the criteria above</p>
            </list-item>
          </list>
          <p>*Based on findings in 147 affected individuals from 44 families</p>
        </sec>
        <sec id="fhm.Establishing_the_Genetic_Cause">
          <title>Establishing the Genetic Cause</title>
          <p>The genetic basis of FHM is established in a proband who meets diagnostic criteria when a heterozygous pathogenic variant is identified in one of the three genes known to be associated with FHM (<italic toggle="yes">CACNA1A</italic>, <italic toggle="yes">ATP1A2,</italic> and <italic toggle="yes">SCN1A</italic>) (see <xref ref-type="table" rid="fhm.T.summary_of_molecular_genetic_testi">Table 1</xref>).</p>
          <p>Note: (1) In the majority of persons with adult-onset hemiplegic migraine without nystagmus, seizures, or other unusual associated neurologic features, the yield for genetic testing is low. (2) Multiple studies have shown that mutation of the three known FHM-related genes is not a major cause of simplex hemiplegic migraine (i.e., hemiplegic migraine in a single person in a family).</p>
          <p><bold>One genetic testing strategy</bold> is serial single gene molecular genetic testing based on the individual&#x02019;s clinical findings (see <xref ref-type="sec" rid="fhm.Clinical_Characteristics">Clinical Characteristics</xref>) and/or the order in which pathogenic variants most commonly occur (i.e., <italic toggle="yes">CACNA1A, ATP1A2, and SCN1A</italic>). Note that those with mutation of <italic toggle="yes">CACNA1A</italic> commonly present with nystagmus and other cerebellar signs [<xref ref-type="bibr" rid="fhm.REF.ophoff.1996.543">Ophoff et al 1996</xref>], and those with mutation of <italic toggle="yes">ATP1A2</italic> frequently have epilepsy [<xref ref-type="bibr" rid="fhm.REF.de_fusco.2003.192">De Fusco et al 2003</xref>].</p>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">CACNA1A, ATP1A2, and SCN1A</italic> and other genes of interest (see <xref ref-type="sec" rid="fhm.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the sensitivity of multi-gene panels vary by laboratory and over time.</p>
          <table-wrap id="fhm.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Familial Hemiplegic Migraine</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup>
<break/>(Locus Name)</th>
                  <th id="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of FHM Attributed to Mutation of This Gene</th>
                  <th id="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">CACNA1A</italic> (FHM1)</td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">3/42 (7%)&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4,&#x000a0;5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">ATP1A2</italic> (FHM2)</td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3/42 (7%)&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1"><italic toggle="yes">SCN1A</italic> (FHM3)</td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="col" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4,&#x000a0;7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_fhm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="fhm.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="fhm" object-id="fhm.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="fhm.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="fhm.TF.1.2">
                <label>2. </label>
                <p>[<xref ref-type="bibr" rid="fhm.REF.thomsen.2007.346">Thomsen et al 2007</xref>].</p>
              </fn>
              <fn id="fhm.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="fhm.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single exon deletions or duplications.</p>
              </fn>
              <fn id="fhm.TF.1.5">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="fhm.REF.dichgans.2005a.371">Dichgans et al [2005a]</xref>
                </p>
              </fn>
              <fn id="fhm.TF.1.6">
                <label>5. </label>
                <p>A 39.5-kb <italic toggle="yes">CACNA1A</italic> deletion of the last 16 coding exons was reported in three affected members of one family with episodic ataxia [<xref ref-type="bibr" rid="fhm.REF.riant.2008.817">Riant et al 2008</xref>].</p>
              </fn>
              <fn id="fhm.TF.1.7">
                <label>7. </label>
                <p>To date, no <italic toggle="yes">SCN1A</italic> deletions or duplications as causative of FHM have been reported.</p>
              </fn>
              <fn id="fhm.TF.1.8">
                <label>8. </label>
                <p>Possible locus heterogeneity: <xref ref-type="bibr" rid="fhm.REF.gardner.1997.1231">Gardner et al [1997]</xref> identified an FHM susceptibility locus on 1q31, designated FHM4/MGR6, which is telomeric to FHM2 (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="omim" xlink:href="607516">607516</ext-link>). <xref ref-type="bibr" rid="fhm.REF.cuencale_n.2009.191">Cuenca-Le&#x000f3;n et al [2009]</xref> mapped an FHM locus to 14q32 in a large Spanish kindred.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="fhm.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="fhm.Clinical_Description">
          <title>Clinical Description</title>
          <p>In migraine with aura, including familial hemiplegic migraine, the neurologic symptoms of aura are unequivocally localizable to the cerebral cortex or brain stem and include <bold>visual disturbance</bold> (most common), <bold>sensory loss</bold> (e.g., numbness or paresthesias of the face or an extremity), and <bold>dysphasia</bold> (difficulty with speech), and for FHM must include <bold>motor involvement</bold> (e.g., hemiparesis [weakness of an extremity]) [<xref ref-type="bibr" rid="fhm.REF.thomsen.2002.1379">Thomsen et al 2002</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Visual disturbances can include scotoma (blind spots), photopsia (flashing lights), fortification spectra (zigzag pattern), and diplopia (double vision).</p>
            </list-item>
            <list-item>
              <p>Dysphasia usually occurs when hemiplegia is right-sided.</p>
            </list-item>
            <list-item>
              <p>Hemiparesis occurs with at least one other symptom during FHM aura [<xref ref-type="bibr" rid="fhm.REF.ducros.2000">Ducros et al 2000</xref>].Note: Recent family studies found that approximately 10% of family members with a <italic toggle="yes">CACNA1A</italic> pathogenic variant do not have hemiplegic attacks but often have migraine with or without aura [<xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al 2001</xref>].</p>
            </list-item>
          </list>
          <p>Some confusion and/or drowsiness may be present even without dysphasia. Impaired consciousness ranging from drowsiness to coma is well described in FHM [<xref ref-type="bibr" rid="fhm.REF.terwindt.1998.1105">Terwindt et al 1998</xref>, <xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>, <xref ref-type="bibr" rid="fhm.REF.vahedi.2000.1040">Vahedi et al 2000</xref>]. Intermittent confusion and psychosis have been reported [<xref ref-type="bibr" rid="fhm.REF.feely.1982.369">Feely et al 1982</xref>] including one probable family with FHM1 and ataxia [<xref ref-type="bibr" rid="fhm.REF.spranger.1999.150">Spranger et al 1999</xref>].</p>
          <p>Neurologic deficits with HM attacks can be prolonged for hours to days and may outlast the associated migrainous headache. Persistent attention and memory loss can last weeks to months [<xref ref-type="bibr" rid="fhm.REF.kors.2003.684">Kors et al 2003</xref>]. Permanent motor, sensory, language, or visual symptoms are extremely rare [<xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al 2001</xref>].</p>
          <p>Cerebral infarction and death have rarely been associated with hemiplegic migraine and should instead raise the possibility of other disorders associated with migraine and stroke (see <xref ref-type="sec" rid="fhm.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
          <p>Familial hemiplegic migraine is often earlier in onset than typical migraine, frequently beginning in the first or second decade. In the report of <xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al [2001]</xref>, the attacks started at a young age in the majority of subjects (mean: 11.7 &#x000b1;8 years; range: 1-51 years). The natural history was variable. The frequency of attacks ranged from one per day to fewer than five in a lifetime (mean: 2-3/year). Long attack-free intervals were often reported (range: 2-37 years). The frequency of FHM attacks tends to decrease with age. The eventual neurologic outcome is often benign in the pure FHM group, although FHM1 can have progressive cerebellar deficit.</p>
          <p>FHM attacks may be provoked by typical migraine triggers (e.g., foods, odors, exertion, stress), minor head trauma, and cerebral angiography.</p>
          <p>Among families with hemiplegic migraine, the major significant clinical differences are presence or absence of cerebellar signs ranging from nystagmus to progressive, usually late-onset mild ataxia, which occurs in up to 40%-50% of families with FHM1 [<xref ref-type="bibr" rid="fhm.REF.ducros.2000">Ducros et al 2000</xref>]; within such families, up to 60% of affected individuals have permanent cerebellar signs [<xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al 2001</xref>].</p>
          <p>Seizures during severe attacks have been reported in some families with FHM2 along with recurrent coma in one individual [<xref ref-type="bibr" rid="fhm.REF.echenne.1999.214">Echenne et al 1999</xref>]. Focal seizures during severe attacks have been described in two individuals with FHM1 who have no family history of FHM1 [<xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>], including one with severe intellectual disability, congenital ataxia, and early cerebellar atrophy [<xref ref-type="bibr" rid="fhm.REF.vahedi.2000.1040">Vahedi et al 2000</xref>].</p>
          <p><bold>Imaging studies.</bold> The only abnormalities observed on traditional imaging studies are vermian cerebellar atrophy in some families with FHM1 [<xref ref-type="bibr" rid="fhm.REF.battistini.1999.38">Battistini et al 1999</xref>]. Rare exceptions include transient diffusion-weighted signal changes on brain MRI suggesting cytotoxic edema during severe prolonged attacks in individuals with FHM1 [<xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>, <xref ref-type="bibr" rid="fhm.REF.vahedi.2000.1040">Vahedi et al 2000</xref>] with hemispheric cerebral atrophy usually contralateral to the hemiparesis [<xref ref-type="bibr" rid="fhm.REF.hayashi.1998.166">Hayashi et al 1998</xref>, <xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>, <xref ref-type="bibr" rid="fhm.REF.vahedi.2000.1040">Vahedi et al 2000</xref>].</p>
          <p>Abnormalities in the cerebellum on magnetic resonance spectroscopy (MRS) have been reported [<xref ref-type="bibr" rid="fhm.REF.dichgans.2005b.608">Dichgans et al 2005b</xref>].</p>
        </sec>
        <sec id="fhm.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">CACNA1A</italic>.</bold> Although further correlation is needed, some suggestive genotype-phenotype correlations exist based on limited data regarding <italic toggle="yes">CACNA1A</italic> pathogenic variants commonly presenting with nystagmus and other cerebellar signs [<xref ref-type="bibr" rid="fhm.REF.ophoff.1996.543">Ophoff et al 1996</xref>, <xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al 2001</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>p.Arg192Gln and p.Val1457Leu [<xref ref-type="bibr" rid="fhm.REF.carrera.1999.26">Carrera et al 1999</xref>] are associated with hemiplegic attacks only, whereas unconsciousness occurs commonly during attacks with the p.Val714Ala pathogenic variant [<xref ref-type="bibr" rid="fhm.REF.terwindt.1998.1105">Terwindt et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p>p.Thr666Met, p.Ile1811Leu, p.Arg583Gln [<xref ref-type="bibr" rid="fhm.REF.alonso.2003.610">Alonso et al 2003</xref>], and p.Asp715Glu [<xref ref-type="bibr" rid="fhm.REF.ducros.1999.89">Ducros et al 1999</xref>] have been associated with hemiplegic attacks plus ataxia. In the <xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al [2001]</xref> study, p.Thr666Met was associated with the highest frequency of hemiplegic migraine, severe attacks of coma, and nystagmus. During attacks, unconsciousness sometimes occurs in individuals with the p.Thr666Met and p.Ile1811Leu pathogenic variants [<xref ref-type="bibr" rid="fhm.REF.terwindt.1998.1105">Terwindt et al 1998</xref>]. <xref ref-type="bibr" rid="fhm.REF.kors.2003.684">Kors et al [2003]</xref> reported a family with the p.Thr666Met pathogenic variant and progressive cognitive dysfunction.</p>
            </list-item>
            <list-item>
              <p>p.Arg583Gln can be associated with stupor, fever, and progressive ataxia [<xref ref-type="bibr" rid="fhm.REF.battistini.1999.38">Battistini et al 1999</xref>, <xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al 2001</xref>]. Affected individuals were thought to have fewer attacks after treatment with acetazolamide.</p>
            </list-item>
            <list-item>
              <p>p.Asp715Glu has the lowest frequency (64%) of attacks of hemiplegic migraine [<xref ref-type="bibr" rid="fhm.REF.ducros.2001.17">Ducros et al 2001</xref>].</p>
            </list-item>
            <list-item>
              <p>A <italic toggle="yes">de novo</italic> mutation p.Tyr1385Cys identified in a single individual with no known family history of FHM has been associated with prolonged severe attacks including focal seizures, coma, fever, and CSF neutrophilic pleocytosis [<xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>, <xref ref-type="bibr" rid="fhm.REF.vahedi.2000.1040">Vahedi et al 2000</xref>]. Cerebral hemispheric and cerebellar atrophy are seen on imaging studies [<xref ref-type="bibr" rid="fhm.REF.vahedi.2000.1040">Vahedi et al 2000</xref>] with reversible MRI signal changes suggestive of cytotoxic edema during attacks [<xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>]. Additionally, the single individual with the p.Thr1384Cys pathogenic variant had otherwise unexplained severe intellectual disability, developmental delay, and congenital or early-onset ataxia.</p>
            </list-item>
            <list-item>
              <p>p.Ser218Leu has been associated with delayed cerebral edema and fatal coma after minor head trauma [<xref ref-type="bibr" rid="fhm.REF.kors.2001.753">Kors et al 2001</xref>].</p>
            </list-item>
          </list>
          <p>See <xref ref-type="table" rid="fhm.T.selected_cacna1a_pathogenic_alleli">Table 2</xref>.</p>
          <p>
            <bold>
              <italic toggle="yes">ATP1A2</italic>
            </bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>In the first two families in which FHM2 was genetically defined, <xref ref-type="bibr" rid="fhm.REF.de_fusco.2003.192">De Fusco et al [2003]</xref> noted the history of seizures in several affected individuals. Subsequent reports of FHM2 further suggest seizures as an associated clinical feature.</p>
            </list-item>
            <list-item>
              <p>A severe phenotype with seizures, coma, and elevated temperature has been reported with a p.Gly301Arg pathogenic variant in <italic toggle="yes">ATP1A2</italic> [<xref ref-type="bibr" rid="fhm.REF.spadaro.2004.177">Spadaro et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>A severe phenotype with seizures and intellectual disability has been reported with the pathogenic variants p.Asp718Asn and p.Pro979Leu [<xref ref-type="bibr" rid="fhm.REF.jurkatrott.2004.1857">Jurkat-Rott et al 2004</xref>].</p>
            </list-item>
          </list>
          <p>See <xref ref-type="table" rid="fhm.T.selected_atp1a2_pathogenic_allelic">Table 3</xref>.</p>
        </sec>
        <sec id="fhm.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance for FHM1, 2, and 3 appears to be high and is estimated to be approximately 80% [<xref ref-type="bibr" rid="fhm.REF.jurkatrott.2004.1857">Jurkat-Rott et al 2004</xref>, <xref ref-type="bibr" rid="fhm.REF.riant.2005.281">Riant et al 2005</xref>].</p>
        </sec>
        <sec id="fhm.Nomenclature">
          <title>Nomenclature</title>
          <p>Although families with FHM in which attacks are strikingly identical do exist, the term familial hemiplegic migraine is often used inconsistently to describe families in which different forms of migraine occur, as most individuals with hemiplegic attacks have these attacks intermingled with more frequent attacks of migraine without hemiparesis.</p>
        </sec>
        <sec id="fhm.Prevalence">
          <title>Prevalence</title>
          <p>In Denmark, <xref ref-type="bibr" rid="fhm.REF.thomsen.2002.1379">Thomsen et al [2002]</xref> found the prevalence of hemiplegic migraine to be 0.01% with a M:F sex ratio of 1:3 and equal prevalence of familial and sporadic cases.</p>
        </sec>
      </sec>
      <sec id="fhm.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold><italic toggle="yes">CACNA1A</italic>.</bold> Two other phenotypes are associated with mutation of <italic toggle="yes">CACNA1A:</italic></p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ea2" document-type="chapter">Episodic ataxia type 2</related-object> (EA2) involving episodes of ataxia and sometimes migrainous headache with interictal nystagmus associated with predominantly nonsense, frameshift, splice site, and multi-exonic deletion mutations that disrupt the open reading frame; some affected individuals have missense mutations.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sca6" document-type="chapter">Spinocerebellar ataxia type 6</related-object> (SCA6) with late-onset progressive ataxia associated with expansion of a CAG trinucleotide repeat in the <italic toggle="yes">CACNA1A</italic> coding region [<xref ref-type="bibr" rid="fhm.REF.zhuchenko.1997.62">Zhuchenko et al 1997</xref>]. Of note, the CAG trinucleotide repeat expansion typical of SCA6 has not been observed in families with FHM [<xref ref-type="bibr" rid="fhm.REF.carrera.1999.26">Carrera et al 1999</xref>, <xref ref-type="bibr" rid="fhm.REF.ducros.1999.89">Ducros et al 1999</xref>]; however, some individuals with SCA6 may have migraine.</p>
          </list-item>
        </list>
        <p>Overlap has been described between the FHM1 phenotype (associated with missense mutations) and the phenotypes of SCA6 and EA2.</p>
        <list list-type="bullet">
          <list-item>
            <p>One family with a CAG trinucleotide repeat expansion characteristically observed in individuals with SCA6 had purely episodic ataxia and another family with a CAG repeat expansion had some members with episodic ataxia and others with progressive ataxia [<xref ref-type="bibr" rid="fhm.REF.jodice.1997.1973">Jodice et al 1997</xref>].</p>
          </list-item>
          <list-item>
            <p>In one family with EA2, affected members experienced hemiplegia; one family member had migraine during episodes of ataxia [<xref ref-type="bibr" rid="fhm.REF.jen.1999.274">Jen 1999</xref>].</p>
          </list-item>
          <list-item>
            <p>In one large family with mutation of <italic toggle="yes">CACNA1A</italic>, some individuals had only hemiplegic migraine, some had only ataxia, and some had both [<xref ref-type="bibr" rid="fhm.REF.alonso.2003.610">Alonso et al 2003</xref>].</p>
          </list-item>
        </list>
        <p><bold><italic toggle="yes">ATP1A2.</italic></bold> Mutation of <italic toggle="yes">ATP1A2</italic> has been associated with another rare clinical condition, alternating hemiplegia of childhood [<xref ref-type="bibr" rid="fhm.REF.bassi.2004.621">Bassi et al 2004</xref>, <xref ref-type="bibr" rid="fhm.REF.swoboda.2004.884">Swoboda et al 2004</xref>].</p>
        <p><bold><italic toggle="yes">SCN1A</italic>.</bold>
<related-object link-type="booklink" source-id="gene" document-id="gefs" document-type="chapter"><italic toggle="yes">SCN1A</italic>-related seizure disorders</related-object> encompass a spectrum that ranges from simple febrile seizures (FS) and generalized epilepsy with febrile seizures plus (GEFS+) at the mild end to Dravet syndrome and intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC) at the severe end. Phenotypes with intractable seizures including Dravet syndrome, also known as severe myoclonic epilepsy in infancy (SMEI) or polymorphic myoclonic epilepsy in infancy (PMEI), are usually associated with progressive dementia. Less commonly observed phenotypes include myoclonic-astatic epilepsy (MAE or Doose syndrome), Lennox-Gastaut syndrome (LGS), infantile spasms, and vaccine-related encephalopathy and seizures. The phenotype can vary even within the same family.</p>
      </sec>
      <sec id="fhm.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Migraine without aura</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/157300">157300</ext-link>). Migraine without aura (MO or MOA) (common migraine) is an idiopathic, recurring headache disorder manifesting in attacks lasting four to 72 hours. Typical characteristics of the headache are unilateral location, pulsating quality, moderate or severe intensity, aggravation by routine physical activity, and association with nausea, photophobia, and phonophobia. This headache occurs without neurologic aura symptoms and specifically without hemiparesis.</p>
        <p>Typical migraine is thought to be genetically complex and to have undefined environmental components. A clinical distinction between familial and nonfamilial cases has long been entertained, beginning with the first report of FHM by <xref ref-type="bibr" rid="fhm.REF.clarke.1910.1534">Clarke [1910]</xref>. <xref ref-type="bibr" rid="fhm.REF.wieser.2003.272">Wieser et al [2003]</xref> found no pathogenic variants in <italic toggle="yes">CACNA1A</italic> in individuals with common migraine. Some families having migraine without aura have shown linkage to 4q21 [<xref ref-type="bibr" rid="fhm.REF.bj_rnsson.2003.986">Bj&#x000f6;rnsson et al 2003</xref>] and 14q21.2-q22.3 [<xref ref-type="bibr" rid="fhm.REF.soragna.2003.161">Soragna et al 2003</xref>]. One family having migraine with or without aura showed linkage to 6p12.2-p21.1 [<xref ref-type="bibr" rid="fhm.REF.carlsson.2002.1804">Carlsson et al 2002</xref>].</p>
        <p><bold>Migraine with aura</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/157300">157300</ext-link>). <xref ref-type="bibr" rid="fhm.REF.brugnoni.2002.1">Brugnoni et al [2002]</xref> found no <italic toggle="yes">CACNA1A</italic> pathogenic variants in individuals with familial migraine with aura. Some families having migraine with aura show linkage to 4q24 [<xref ref-type="bibr" rid="fhm.REF.wessman.2002.652">Wessman et al 2002</xref>].</p>
        <p><bold>"Sporadic" hemiplegic migraine (SHM).</bold> "Sporadic" hemiplegic migraine refers to simplex cases (i.e., affected individuals with no relatives with hemiplegic migraine). Such individuals may or may not have other family members with typical migraine. To investigate the genetic basis of hemiplegic migraine in simplex cases:</p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="fhm.REF.terwindt.2002.1016">Terwindt et al [2002]</xref> evaluated 27 individuals who had no family history of hemiplegic migraine and found a pathogenic variant in <italic toggle="yes">CACNA1A</italic> in two, one of whom had ataxia, nystagmus, and cerebellar atrophy on cranial CT; the other did not.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="fhm.REF.de_vries.2007.2170">de Vries et al [2007]</xref> sequenced all three FHM-related genes in 39 individuals with SHM and found one <italic toggle="yes">CACNA1A</italic> pathogenic variant (FHM1), five <italic toggle="yes">ATP1A2</italic> pathogenic variants (FHM2), and one <italic toggle="yes">SCN1A</italic> benign variant (FHM3).</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="fhm.REF.thomsen.2008.914">Thomsen et al [2008]</xref> examined 100 individuals with SHM and found only a handful of novel, not clearly pathogenic nucleotide variants in <italic toggle="yes">CACNA1A</italic> and <italic toggle="yes">ATP1A2</italic>, suggesting that FHM-related genes are not major genes in SHM.</p>
          </list-item>
        </list>
        <p>Other inherited disorders associated with migrainous headache that may include hemiplegic aura:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter"><bold>MELAS</bold></related-object><bold>,</bold>
<related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter"><bold>MERRF</bold></related-object><bold>, and other</bold>
<related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter"><bold>mitochondrial disorders</bold></related-object><bold>.</bold> MELAS is a multisystem disorder with onset typically between ages two and ten years. The most common initial symptoms are generalized tonic-clonic seizures, recurrent headaches, anorexia, and recurrent vomiting. Seizures are often associated with stroke-like episodes of transient hemiparesis or cortical blindness, which may be associated with altered consciousness and may be recurrent. The cumulative residual effects of the stroke-like episodes gradually impair motor abilities, vision, and cognition, often by adolescence or young adulthood. Sensorineural hearing loss is common. The most common mitochondrial DNA (mtDNA) pathogenic variant, present in more than 80% of individuals with typical clinical findings of MELAS, is an A-to-G transition at nucleotide 3243 in the tRNALeu(UUR) of mtDNA.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter"><bold>CADASIL</bold></related-object> (<italic toggle="yes">c</italic>erebral <italic toggle="yes">a</italic>utosomal <italic toggle="yes">d</italic>ominant <italic toggle="yes">a</italic>rteriopathy with <italic toggle="yes">s</italic>ubcortical <italic toggle="yes">i</italic>nfarcts and <italic toggle="yes">l</italic>eukoencephalopathy) is characterized by history of migraine with aura, mid-adult (30s-60s) onset of cerebrovascular, mood disturbance, apathy, cognitive disturbance progressing to dementia, and diffuse white matter lesions and subcortical infarcts on neuroimaging. One family with CADASIL was reported to have hemiparetic aura [<xref ref-type="bibr" rid="fhm.REF.hutchinson.1995.817">Hutchinson et al 1995</xref>]. The pathologic hallmark of CADASIL is electron-dense granules in the media of arterioles that can often be identified by electron microscopic (EM) evaluation of skin biopsies. More than 90% of individuals have pathogenic variants in <italic toggle="yes">NOTCH3</italic>. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><bold>RVCL</bold> (<italic toggle="yes">r</italic>etinal <italic toggle="yes">v</italic>asculopathy with <italic toggle="yes">c</italic>erebral <italic toggle="yes">l</italic>eukodystrophy) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/192315">192315</ext-link>) is characterized by systemic microvasculopathy with adult onset (30s-40s) of retinal vasculopathy and cerebrovascular disease variably associated with migraine. The pathologic hallmark of RVCL is multi-laminated subendothelial basement membrane by EM evaluation of multiple organs including skin. Affected individuals have pathogenic variants in <italic toggle="yes">TREX1</italic>. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter"><bold>Hereditary hemorrhagic telangiectasia</bold></related-object> (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. Small AVMs, or telangiectases, close to the surface of skin and mucous membranes often rupture and bleed after slight trauma. The most common clinical manifestation is spontaneous and recurrent nosebleeds beginning at approximately age 12 years. Large AVMs often cause symptoms when they occur in brain, lung, or the gastrointestinal tract; complications from bleeding or shunting may be sudden and catastrophic. Migraine with aura has been reported in 50% of affected individuals. HHT is caused by pathogenic variants in <italic toggle="yes">ENG</italic>, <italic toggle="yes">ACVRL1</italic>, <italic toggle="yes">SMAD4</italic>, and at least two other as-yet unidentified genes. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ccm" document-type="chapter"><bold>Familial cerebral cavernous malformations</bold></related-object> (CCMs) are vascular malformations in the brain and spinal cord consisting of closely clustered enlarged capillary channels (caverns) with a single layer of endothelium without normal intervening brain parenchyma or mature vessel wall elements. CCMs have been reported in infants and children, but the majority of individuals present with symptoms between the second and fifth decades. Approximately 50%-75% of persons with CCM have symptoms, including seizures, focal neurologic deficits, nonspecific headaches, and cerebral hemorrhage. Up to 50% of individuals with CCM remain symptom free throughout their lives. The three genes associated with familial CCM are <italic toggle="yes">KRIT1</italic>, <italic toggle="yes">CCM2</italic>, and <italic toggle="yes">CCM3</italic>. Inheritance is autosomal dominant.</p>
          </list-item>
          <list-item>
            <p><bold>Dutch form of</bold> hereditary cerebral amyloid angiopathy (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/605714">605714</ext-link>). Migraines often precede the onset of cerebral and cerebellar hemorrhage in the fourth or fifth decade. Senile plaques and vascular wall amyloid are found in the brain in association with amino acid changes in the APP beta-amyloid precursor protein, a protease inhibitor. Inheritance is autosomal dominant.</p>
          </list-item>
        </list>
        <p><bold>Alternating hemiplegia of childhood (AHC)</bold> is a rare condition with clinical features that overlap with FHM. AHC is characterized by recurrent hemiplegia with onset before age 18 months, variable other transient neurological findings, and progressive cognitive decline<bold>.</bold> Some individuals with AHC have a heterozygous pathogenic variant in <italic toggle="yes">ATP1A2</italic> (the gene that is mutated in FHM2) [<xref ref-type="bibr" rid="fhm.REF.bassi.2004.621">Bassi et al 2004</xref>, <xref ref-type="bibr" rid="fhm.REF.swoboda.2004.884">Swoboda et al 2004</xref>]; however, the majority are heterozygous for a pathogenic variant in <italic toggle="yes">ATP1A3</italic> [<xref ref-type="bibr" rid="fhm.REF.heinzen.2012.1030">Heinzen et al 2012</xref>] and are allelic with rapid-onset dystonia parkinsonism and CAPOS. Inheritance is autosomal dominant.</p>
        <p><bold>Hemiplegia.</bold> The differential diagnosis of hemiplegia includes post-ictal weakness following seizure, transient ischemic attack (TIA), stroke, and other non-genetic causes of transient hemiparesis.</p>
        <p><bold>Stroke.</bold> When family history is positive for hemiparetic attacks with migraine, the presence of infarct on imaging studies raises the possibility of other inherited disorders such as <related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter">CADASIL</related-object>, or thrombophilia, such as <related-object link-type="booklink" source-id="gene" document-id="factor-v-leiden" document-type="chapter">factor V Leiden</related-object> [<xref ref-type="bibr" rid="fhm.REF.gaustadnes.1999.251">Gaustadnes et al 1999</xref>]. Additional stroke risk factors may also be present.</p>
        <p>Caution: Even with normal imaging studies and description of spreading aura, an age-appropriate stroke evaluation should be considered at presentation. Overlap in clinical features, inaccuracies of historical family information, rarity of true FHM, and the seriousness of stroke-related disorders warrant this cautious approach. Stroke or other CNS-related disorders should be even more strongly considered if family history is negative for hemiplegic migraine.</p>
      </sec>
      <sec id="fhm.Management_1">
        <title>Management</title>
        <sec id="fhm.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with familial or sporadic hemiplegic migraine, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Quantitative eye movement examination in individuals with nystagmus or complaints of incoordination or imbalance to look for additional clues of cerebellar involvement</p>
            </list-item>
            <list-item>
              <p>EEG and neuroimaging studies if seizures are present in order to further characterize the seizure disorder.</p>
            </list-item>
            <list-item>
              <p>Consultation with a medical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="fhm.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Symptomatic support during an episode of hemiplegic migraine is the only therapy available.</p>
          <p>A trial of acetazolamide for individuals with FHM1 or a trial of standard migraine prophylactic drugs (tricyclic antidepressants, beta blockers, calcium channel blockers, anti-epileptic medications) for all FHM types may be warranted for frequent attacks. Limited correlation exists between drug response and hemiplegic migraine type.</p>
          <p>There are anecdotal reports of therapeutic response to antiepileptic medications including topiramate, lacosamide, levetiracetam, and valproate, along with other medications commonly used for migraine prophylaxis.</p>
          <p>Antiepileptic treatment may be necessary for seizures that are prevalent in FHM2 (caused by mutation of <italic toggle="yes">ATP1A2)</italic>.</p>
        </sec>
        <sec id="fhm.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>In general, vasoconstricting agents should be avoided because of the risk of stroke.</p>
          <p>Cerebral angiography is hazardous as it may precipitate a severe attack [<xref ref-type="bibr" rid="fhm.REF.chabriat.2000.510">Chabriat et al 2000</xref>].</p>
        </sec>
        <sec id="fhm.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="fhm.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="fhm.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="fhm.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="fhm.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Familial hemiplegic migraine is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="fhm.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Because the diagnosis of FHM requires at least one affected first-degree relative, most individuals diagnosed with familial hemiplegic migraine have an affected parent.</p>
            </list-item>
            <list-item>
              <p>The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">CACNA1A</italic>, <italic toggle="yes">ATP1A2</italic>, or <italic toggle="yes">SCN1A</italic> is unknown but probably low.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Limited data for FHM have been reported [<xref ref-type="bibr" rid="fhm.REF.carrera.1999.26">Carrera et al 1999</xref>, <xref ref-type="bibr" rid="fhm.REF.ducros.1999.89">Ducros et al 1999</xref>].</p>
                </list-item>
                <list-item>
                  <p>Twenty-three of 25 individuals with early onset hemiplegic migraine (mean age of clinical onset 7.7 +/- 3.4 years) had a heterozygous pathogenic variant in <italic toggle="yes">CACNA1A</italic> or <italic toggle="yes">ATP1A2</italic>. Nineteen of 23 were <italic toggle="yes">de novo</italic> (i.e., not identified in either parent) [<xref ref-type="bibr" rid="fhm.REF.riant.2010.967">Riant et al 2010</xref>].</p>
                </list-item>
                <list-item>
                  <p><italic toggle="yes">De novo</italic> mutation of a FHM-related gene has been reported in &#x0201c;sporadic&#x0201d; hemiplegic migraine (see <xref ref-type="sec" rid="fhm.Differential_Diagnosis">Differential Diagnosis</xref>) in a small number of simplex cases (i.e., single occurrences of FHM in a family) [<xref ref-type="bibr" rid="fhm.REF.terwindt.2002.1016">Terwindt et al 2002</xref>, <xref ref-type="bibr" rid="fhm.REF.de_vries.2007.2170">de Vries et al 2007</xref>, <xref ref-type="bibr" rid="fhm.REF.thomsen.2008.914">Thomsen et al 2008</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of an individual with an apparent <italic toggle="yes">de novo</italic> mutation include clinical interview, neurologic examination, and molecular genetic testing if the pathogenic variant has been identified in the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of a proband depends on the genetic status of the parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant in the proband cannot be detected in the DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> mutation in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with familial hemiplegic migraine has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the genetic status of the proband's parents. If a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="fhm.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk of being affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="fhm.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">CACNA1A, ATP1A2, or SCN1A</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of these genes or custom prenatal testing.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">CACNA1A, ATP1A2, or SCN1A</italic> pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="fhm.Resources">
        <title>Resources</title>
      </sec>
      <sec id="fhm.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">CACNA1A</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The gene comprises 47 exons spanning 300 kb. It is alternatively spliced, notably with an alternative exon 37 [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001127221.1">NM_001127221.1</ext-link> RefSeq transcript variant 3] and an alternative splice site for exon 47 which contains polymorphic CAG repeats, with the longer transcript rendering the CAG repeats in frame for polyglutamine. Pathogenic variants have been identified in exon 37a and exon 37b. Furthermore, CAG repeat expansions with more than 21 repeats cause SCA6 link with incomplete penetrance. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fhm" object-id="fhm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> The pathogenic variant p.Thr666Met is the most common, with no evidence for founder effect [<xref ref-type="bibr" rid="fhm.REF.ducros.1999.89">Ducros et al 1999</xref>]. See <xref ref-type="table" rid="fhm.T.selected_cacna1a_pathogenic_alleli">Table 2</xref>.</p>
        <table-wrap id="fhm.T.selected_cacna1a_pathogenic_alleli" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">CACNA1A</italic> Pathogenic Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.575G&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg192Gln</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_3" rowspan="9" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001127221.1">NM_001127221.1</ext-link><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001120693.1">NP_001120693.1</ext-link><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/1657332">X99897</ext-link>&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.653C&#x0003e;T</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser218Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1748G&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg583Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2141T&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val714Ala</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2145C&#x0003e;G</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp715Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1997C&#x0003e;T</td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr666Met</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4151A&#x0003e;G<break/>(c.4154A&#x0003e;G)&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr1384Cys<break/>(p.Tyr1385Cys)&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.5428A&#x0003e;C<break/>(c.5431A&#x0003e;C)&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile1810Leu<break/>(p.Ile1811Leu)&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4366G&#x0003e;T<break/>(c.4369G&#x0003e;T)&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_fhm.T.selected_cacna1a_pathogenic_alleli_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val1456Leu<break/>(p.Val1457Leu)&#x000a0;<sup>2</sup></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="fhm.TF.2.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
            <fn id="fhm.TF.2.2">
              <label>2. </label>
              <p>Variant designations are given for an alternate reference sequence. X99897 is an alternate cDNA commonly used in the literature. Compared to NM_001127221.1, it has an extra three nucleotides (AAG) at nucleotide 3623_3625, resulting in an additional Glu residue.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The gene encodes the alpha-1 subunit of a neural voltage-dependent P/Q-type calcium channel important in synaptic transmission in the central nervous system as well as at the neuromuscular junction. The alpha-1 subunit forms the voltage sensor and pore of the calcium channel.</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants affect the pore or the voltage sensor parts of the ion channel. <xref ref-type="bibr" rid="fhm.REF.tottene.2002.13284">Tottene et al [2002]</xref> found that mutational changes of functional channel densities can be different in different cell types, and identified two functional effects common to all FHM-causing pathogenic variants analyzed: increase of single-channel Ca<sup>2+</sup> influx and decrease of maximal Ca(V)2.1 current density in neurons.</p>
        <p>Subsequent studies in FHM1 knockin mouse models further demonstrated enhanced excitatory (but not inhibitory) synaptic neurotransmission as the basis for facilitated spreading depression thought to underlie migraine in humans [<xref ref-type="bibr" rid="fhm.REF.tottene.2009.762">Tottene et al 2009</xref>, <xref ref-type="bibr" rid="fhm.REF.di_guilmi.2014.7047">Di Guilmi et al 2014</xref>, <xref ref-type="bibr" rid="fhm.REF.vecchia.2014.225">Vecchia et al 2014</xref>, <xref ref-type="bibr" rid="fhm.REF.vecchia.2015.8">Vecchia et al 2015</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">ATP1A2</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold> The gene has 23 exons spanning 25 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fhm" object-id="fhm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Since the first report of p.Leu764Pro and p.Trp887Arg [<xref ref-type="bibr" rid="fhm.REF.de_fusco.2003.192">De Fusco et al 2003</xref>], more than 80 pathogenic variants in <italic toggle="yes">ATP1A2</italic> have been described in FHM2 or sporadic hemiplegic migraine.</p>
        <p>The great majority are missense pathogenic variants, with a handful of frameshift pathogenic variants [<xref ref-type="bibr" rid="fhm.REF.riant.2005.281">Riant et al 2005</xref>].</p>
        <p>A <italic toggle="yes">de novo</italic> nonsense pathogenic variant with premature termination p.Tyr1009Ter was identified in a child with sporadic hemiplegic migraine and epilepsy [<xref ref-type="bibr" rid="fhm.REF.gallanti.2008.123">Gallanti et al 2008</xref>].</p>
        <p>A single nucleotide variant was predicted to lead to p.Ter1021Arg (*1021R), with alteration of the termination code to add 28 novel amino acid residues to the C terminus [<xref ref-type="bibr" rid="fhm.REF.jurkatrott.2004.1857">Jurkat-Rott et al 2004</xref>]. See <xref ref-type="table" rid="fhm.T.selected_atp1a2_pathogenic_allelic">Table 3</xref>.</p>
        <table-wrap id="fhm.T.selected_atp1a2_pathogenic_allelic" position="anchor" orientation="portrait">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">ATP1A2</italic> Pathogenic Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.901G&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly301Arg</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_3" rowspan="8" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_000702.3">NM_000702.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_000693.1">NP_000693.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2066G&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg689Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2152G&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp718Asn</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2192T&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met731Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2291T&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu764Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2659T&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Trp887Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2936C&#x0003e;T</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro979Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">3061T&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_atp1a2_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ter1021Argext28<break/>(also known as p.X1021Arg)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="fhm.TF.3.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> A heterodimeric protein, expressed largely in astrocytes, has ten transmembrane domains with a large catalytic &#x003b1;-subunit and a smaller ancillary &#x003b2;-subunit. The pump hydrolyzes ATP to exchange intracellular Na+ for extracellular K+ to maintain not only the resting potential but also the electrochemical gradient that drives transporters.</p>
        <p><bold>Abnormal gene product.</bold> The two pathogenic variants found by <xref ref-type="bibr" rid="fhm.REF.de_fusco.2003.192">De Fusco et al [2003]</xref>, p.Leu764Pro and p.Trp887Arg, cause loss of function of the &#x003b1;2-subunit leading to haploinsufficiency, which appears to be the general rule for FHM2-causing pathogenic variants. Expression studies of mostly missense mutations and p.Ter1021Argext28 revealed important functional domains for protein conformation, plasma membrane targeting, turnover, cation affinity, and voltage dependence [<xref ref-type="bibr" rid="fhm.REF.tavraz.2008.31097">Tavraz et al 2008</xref>]. The p.Ter1021Argext28 pathogenic variant changes the stop codon (*) to Arg and extends the protein by a total of 28 amino acids.</p>
        <p>
          <bold>
            <italic toggle="yes">SCN1A</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">SCN1A</italic> comprises 26 exons spanning 82 kb.</p>
        <p><bold>Pathogenic allelic variants</bold> associated with FHM include p.Leu263Val [<xref ref-type="bibr" rid="fhm.REF.castro.2009.308">Castro et al 2009</xref>], p.Thr1174Ser [<xref ref-type="bibr" rid="fhm.REF.gargus.2007.407">Gargus &#x00026; Tournay 2007</xref>], p.Gln1489Lys [<xref ref-type="bibr" rid="fhm.REF.dichgans.2005a.371">Dichgans et al 2005a</xref>], p.Leu1649Gln [<xref ref-type="bibr" rid="fhm.REF.vanmolkot.2007.522">Vanmolkot et al 2007</xref>], as well as p.Phe1499Leu and p.Gln1489His [<xref ref-type="bibr" rid="fhm.REF.vahedi.2009.1178">Vahedi et al 2009</xref>]. See <xref ref-type="table" rid="fhm.T.selected_scn1a_pathogenic_allelic">Table 4</xref>. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fhm" object-id="fhm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <table-wrap id="fhm.T.selected_scn1a_pathogenic_allelic" position="anchor" orientation="portrait">
          <label>Table 4. </label>
          <caption>
            <p>Selected <italic toggle="yes">SCN1A</italic> Pathogenic Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.787C&#x0003e;G</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu263Val</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=AB093548.1">AB093548.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3521C&#x0003e;G</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr1174Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4465C&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln1489Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4467G&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln1489His</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4495T&#x0003e;C</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe1499Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4946T&#x0003e;A</td>
                <td headers="hd_h_fhm.T.selected_scn1a_pathogenic_allelic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu1649Gln</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The gene encodes the voltage-sensing and ion-conducting &#x003b1;1-subunit of a neural voltage-dependent sodium channel.</p>
        <p><bold>Abnormal gene product.</bold> The pathogenic variants p.Gln1489Lys and p.Leu1649Gln associated with pure hemiplegic migraine showed loss of channel function, while p.Leu263Val associated with both hemiplegic migraine and epilepsy exhibited gain of channel function [<xref ref-type="bibr" rid="fhm.REF.kahlig.2008.9799">Kahlig et al 2008</xref>].</p>
      </sec>
      <sec id="fhm.References">
        <title>References</title>
        <sec id="fhm.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="fhm.Literature_Cited.reflist0">
            <ref id="fhm.REF.alonso.2003.610">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coelho</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silveira</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coutinho</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>610</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12707077</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.bassi.2004.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nazos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crippa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baschirotto</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zucca</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bersano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolcetta</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boneschi</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood.</article-title>
                <source>J Med Genet.</source>
                <year>2004</year>
                <volume>41</volume>
                <fpage>621</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15286158</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.battistini.1999.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Battistini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenirri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piatti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelfi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Righetti</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocchi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battistini</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guazzi</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrera</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>38</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">10408534</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.bj_rnsson.2003.986">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bj&#x000f6;rnsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gudmundsson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gudfinnsson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hrafnsdottir</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benedikz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skuladottir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristjansson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frigge</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulcher</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Localization of a Gene for Migraine without Aura to Chromosome 4q21.</article-title>
                <source>Am J Hum Genet</source>
                <volume>73</volume>
                <fpage>986</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">14513409</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.brugnoni.2002.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brugnoni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigamonti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moranduzzo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornelio</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantegazza</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bussone</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Is the CACNA1A gene involved in familial migraine with aura?</article-title>
                <source>Neurol Sci</source>
                <volume>23</volume>
                <fpage>1</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12111613</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.carlsson.2002.1804">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carlsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsgren</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nylander</surname>
                    <given-names>PO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellman</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsman-Semb</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmgren</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1804</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12473779</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.carrera.1999.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carrera</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piatti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenirri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimaldi</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchioni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curcio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Righetti</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelfi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Genetic heterogeneity in Italian families with familial hemiplegic migraine.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>26</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10408532</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.castro.2009.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeiros</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira-Monteiro</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy.</article-title>
                <source>Cephalalgia</source>
                <volume>29</volume>
                <fpage>308</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">19220312</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.chabriat.2000.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chabriat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poupon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Bihan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene.</article-title>
                <source>Neurology</source>
                <volume>54</volume>
                <fpage>510</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">10668728</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.clarke.1910.1534">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1910</year>
                <article-title>On recurrent motor paralysis in migraine.</article-title>
                <source>Br Med J</source>
                <volume>1</volume>
                <fpage>1534</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20765161</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.cuencale_n.2009.191">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cuenca-Le&#x000f3;n</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corominas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montfort</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artigas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bay&#x000e9;s</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormand</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macaya</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred.</article-title>
                <source>Neurogenetics</source>
                <volume>10</volume>
                <fpage>191</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19153782</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.de_fusco.2003.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atorino</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aridon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>192</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12539047</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.de_vries.2007.2170">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenderink</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Boogerd</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Heuvel</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine.</article-title>
                <source>Neurology</source>
                <volume>69</volume>
                <fpage>2170</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18056581</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.di_guilmi.2014.7047">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Guilmi</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inchauspe</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsythe</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borst</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchitel</surname>
                    <given-names>OD</given-names>
                  </name>
                </person-group>
                <article-title>Synaptic gain-of-function effects of mutant Cav2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca2+]i.</article-title>
                <source>J Neurosci.</source>
                <year>2014</year>
                <volume>34</volume>
                <fpage>7047</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">24849341</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.dichgans.2005a.371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eckstein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz-Depiereux</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biskup</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                </person-group>
                <year>2005a</year>
                <article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.</article-title>
                <source>Lancet</source>
                <volume>366</volume>
                <fpage>371</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16054936</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.dichgans.2005b.608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>2005b</year>
                <article-title>1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>608</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">15728280</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.ducros.2001.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cecillon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lescoat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darcel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicaut</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.</article-title>
                <source>N Engl J Med</source>
                <volume>345</volume>
                <fpage>17</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">11439943</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.ducros.1999.89">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darcel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madigand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerouaou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Julien</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chedru</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bisgard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucotte</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Despres</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barthez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>64</volume>
                <fpage>89</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">9915947</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.ducros.2000">
              <mixed-citation publication-type="book">Ducros A, Joutel A, Vahedi K, Bousser MG, Tournier-Lasserve E. Genotype-phenotype correlations in familial hemiplegic migraine. In: Olesen J, Bousser MG, eds. <italic toggle="yes">Frontiers in Headache Research: Genetics of Headache Disorders</italic>. Vol 8. Philadelphia, PA: Lippincott, Williams, &#x00026; Wilkins; 2000:123-7.</mixed-citation>
            </ref>
            <ref id="fhm.REF.echenne.1999.214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Echenne</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivier</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Humbertclaude</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roubertie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azais</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1.</article-title>
                <source>Neuropediatrics</source>
                <volume>30</volume>
                <fpage>214</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10569214</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.feely.1982.369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feely</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Hare</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callaghan</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Episodes of acute confusion or psychosis in familial hemiplegic migraine.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>65</volume>
                <fpage>369</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">7102264</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.gallanti.2008.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallanti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bussone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures.</article-title>
                <source>J Neurol Sci</source>
                <volume>273</volume>
                <fpage>123</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18644608</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.gardner.1997.1231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barmada</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ptacek</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A new locus for hemiplegic migraine maps to chromosome 1q31.</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1231</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9371899</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.gargus.2007.407">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gargus</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournay</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel mutation confirms seizure locus SCN1A is also familial hemiplegic migraine locus FHM3.</article-title>
                <source>Pediatr Neurol</source>
                <volume>37</volume>
                <fpage>407</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">18021921</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.gaustadnes.1999.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaustadnes</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudiger</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjerregaard Larsen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ingerslev</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients.</article-title>
                <source>Blood Coagul Fibrinolysis</source>
                <volume>10</volume>
                <fpage>251</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10456616</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.hayashi.1998.166">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tachikawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsumata</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Familial hemiplegic migraine with irreversible brain damage.</article-title>
                <source>Intern Med</source>
                <volume>37</volume>
                <fpage>166</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9550598</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.headache_classification_subcommittee_of_the_international_headache_society.2004.9">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>Headache Classification Subcommittee of the International Headache Society</collab>
                </person-group>
                <article-title><italic toggle="yes">The International Classification of Headache Disorders</italic>. 2 ed.</article-title>
                <source>Cephalalgia</source>
                <volume>24</volume>
                <fpage>9</fpage>
                <lpage>160</lpage>
                <year>2004</year>
                <pub-id pub-id-type="pmid">14979299</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.heinzen.2012.1030">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heinzen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hitomi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walley</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heavin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panagiotakaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <collab>European Alternating Hemiplegia of Childhood (AHC) Genetics Consortium</collab>
                </person-group>
                <article-title>Biobanca e Registro Clinico per l'Emiplegia Alternante (I.B.AHC) Consortium; European Network for Research on Alternating Hemiplegia (ENRAH) for Small and Medium-sized Enterpriese (SMEs) Consortium, Fiori S, Abiusi E, Di Pietro L, Sweney MT, Newcomb TM, Viollet L, Huff C, Jorde LB, Reyna SP, Murphy KJ, Shianna KV, Gumbs CE, Little L, Silver K, Pt&#x000e1;&#x0010d;ek LJ, Haan J, Ferrari MD, Bye AM, Herkes GK, Whitelaw CM, Webb D, Lynch BJ, Uldall P, King MD, Scheffer IE, Neri G, Arzimanoglou A, van den Maagdenberg AM, Sisodiya SM, Mikati MA, Goldstein DB. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>1030</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22842232</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.hutchinson.1995.817">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hutchinson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Riordan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macerlaine</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parfrey</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagy</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Familial hemiplegic migraine and autosomal dominant arteriopathy with leukoencephalopathy (CADASIL).</article-title>
                <source>Ann Neurol</source>
                <volume>38</volume>
                <fpage>817</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">7486874</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.jen.1999.274">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Calcium channelopathies in the central nervous system.</article-title>
                <source>Curr Opin Neurobiol</source>
                <volume>9</volume>
                <fpage>274</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">10395579</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.jodice.1997.1973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jodice</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantuano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veneziano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trettel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabbadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calandriello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadaro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frontali</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1973</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9302278</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.jurkatrott.2004.1857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jurkat-Rott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreier</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herzog</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petzold</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>1857</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">15159495</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.kahlig.2008.9799">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kahlig</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhodes</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereira-Monteiro</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>AL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Divergent sodium channel defects in familial hemiplegic migraine.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>105</volume>
                <fpage>9799</fpage>
                <lpage>804</lpage>
                <pub-id pub-id-type="pmid">18621678</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.kors.2003.684">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kors</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giffin</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pazdera</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnittger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lennox</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>684</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12756131</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.kors.2001.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kors</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzsimons</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardine</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heywood</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Love</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>753</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11409427</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.ophoff.1996.543">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergouwe</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Eijk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oefner</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamerdin</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohrenweiser</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindhout</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Ommen</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofker</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.</article-title>
                <source>Cell</source>
                <volume>87</volume>
                <fpage>543</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">8898206</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.riant.2005.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aridon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maciazek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>ATP1A2 mutations in 11 families with familial hemiplegic migraine.</article-title>
                <source>Hum Mutat</source>
                <volume>26</volume>
                <fpage>281</fpage>
                <pub-id pub-id-type="pmid">16088919</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.riant.2010.967">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbance</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>75</volume>
                <fpage>967</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">20837964</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.riant.2008.817">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mourtada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saugier-Veber</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Large CACNA1A deletion in a family with episodic ataxia type 2.</article-title>
                <source>Arch Neurol</source>
                <volume>65</volume>
                <fpage>817</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">18541804</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.soragna.2003.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Soragna</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vettori</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carraro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchioni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vazza</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tupler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savoldi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mostacciuolo</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A locus for migraine without aura maps on chromosome 14q21.2-q22.3.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>161</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12474141</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.spadaro.2004.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spadaro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ursu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veneziano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giunti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frontali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkat-Rott</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs.</article-title>
                <source>Neurogenetics</source>
                <volume>5</volume>
                <fpage>177</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15459825</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.spranger.1999.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwab</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benninger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis.</article-title>
                <source>Eur Neurol</source>
                <volume>41</volume>
                <fpage>150</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">10202246</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.swoboda.2004.884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanavakis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xaidara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger-Massart</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ptacek</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Youroukos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation.</article-title>
                <source>Ann Neurol.</source>
                <year>2004</year>
                <volume>55</volume>
                <fpage>884</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15174025</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.tavraz.2008.31097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tavraz</surname>
                    <given-names>NN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrich</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenderink</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2.</article-title>
                <source>J Biol Chem</source>
                <volume>283</volume>
                <fpage>31097</fpage>
                <lpage>106</lpage>
                <pub-id pub-id-type="pmid">18728015</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.terwindt.2002.1016">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kors</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeulen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Maagdenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutation analysis of the CACNA1A calcium channel subunit gene in 27 patients with sporadic hemiplegic migraine.</article-title>
                <source>Arch Neurol.</source>
                <year>2002</year>
                <volume>59</volume>
                <fpage>1016</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12056940</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.terwindt.1998.1105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vergouwe</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Eijk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1105</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9566402</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.thomsen.2002.1379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomsen</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksen</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roemer</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olesen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria.</article-title>
                <source>Brain</source>
                <volume>125</volume>
                <fpage>1379</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">12023326</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.thomsen.2007.346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomsen</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirchmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasquel</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petursson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frigge</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulcher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olesen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The genetic spectrum of a population-based sample of familial hemiplegic migraine.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>346</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">17142831</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.thomsen.2008.914">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomsen</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oestergaard</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjornsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasquel</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulcher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stefansson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olesen</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients.</article-title>
                <source>Cephalalgia</source>
                <volume>28</volume>
                <fpage>914</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">18513263</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.tottene.2009.762">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tottene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabbro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vecchia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shapovalova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santello</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrobon</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice.</article-title>
                <source>Neuron.</source>
                <year>2009</year>
                <volume>61</volume>
                <fpage>762</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">19285472</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.tottene.2002.13284">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tottene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fellin</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagnutti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luvisetto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striessnig</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrobon</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>99</volume>
                <fpage>13284</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12235360</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.vahedi.2000.1040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousson</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabriat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haguenau</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1040</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11061267</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.vahedi.2009.1178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Fort</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaine</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trouillard</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaudric</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leguern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations.</article-title>
                <source>Neurology.</source>
                <volume>72</volume>
                <fpage>1178</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">19332696</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.vanmolkot.2007.522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freilinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norris</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramadan</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online.</article-title>
                <source>Hum Mutat</source>
                <volume>28</volume>
                <fpage>522</fpage>
                <pub-id pub-id-type="pmid">17397047</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.vecchia.2015.8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vecchia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tottene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrobon</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Abnormal cortical synaptic transmission in CaV2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans.</article-title>
                <source>Front Cell Neurosci.</source>
                <year>2015</year>
                <volume>9</volume>
                <fpage>8</fpage>
                <pub-id pub-id-type="pmid">25741235</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.vecchia.2014.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vecchia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tottene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrobon</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in CaV2.1 knockin migraine mice.</article-title>
                <source>Neurobiol Dis.</source>
                <year>2014</year>
                <volume>69</volume>
                <fpage>225</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">24907493</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.wessman.2002.652">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wessman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaunisto</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marttila</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartiala</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oswell</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leal</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joslyn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovatta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiekkalinna</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaprio</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantor</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zwart</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilmavirta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Havanka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farkkila</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A susceptibility locus for migraine with aura, on chromosome 4q24.</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>652</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">11836652</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.wieser.2003.272">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wieser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zierz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deufel</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Absence of known familial hemiplegic migraine (FHM) mutations in the CACNA1A gene in patients with common migraine: implications for genetic testing.</article-title>
                <source>Clin Chem Lab Med</source>
                <volume>41</volume>
                <fpage>272</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12705332</pub-id>
              </element-citation>
            </ref>
            <ref id="fhm.REF.zhuchenko.1997.62">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhuchenko</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashizawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockton</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Subramony</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoghbi</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.</article-title>
                <source>Nat Genet.</source>
                <year>1997</year>
                <volume>15</volume>
                <fpage>62</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8988170</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="fhm.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="fhm.Author_History">
          <title>Author History</title>
          <p>Kathy Lou Gardner, MD; University of Pittsburgh (2001-2009)Joanna C Jen, MD, PhD (2009-present)</p>
        </sec>
        <sec id="fhm.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>14 May 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 September 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 January 2007 (cd) Revision: mutations in <italic toggle="yes">SCN1A</italic> associated with familial hemiplegic migraine type 3</p>
            </list-item>
            <list-item>
              <p>14 December 2004 (cd) Revision: sequence analysis of <italic toggle="yes">CACNA1A</italic> clinically available</p>
            </list-item>
            <list-item>
              <p>15 March 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 December 2003 (cd) Revision: change in test availability</p>
            </list-item>
            <list-item>
              <p>3 October 2002 (kg) Author revisions</p>
            </list-item>
            <list-item>
              <p>16 September 2002 (kg) Author revisions</p>
            </list-item>
            <list-item>
              <p>17 July 2001 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>October 2000 (kg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
